Barrett’s Esophagus

Clinical Trial Info

  • Category

    Featured Trials

The exact cause of Barrett’s esophagus is not fully understood, but long-term GERD is the number one risk factor. Not all people with GERD get Barrett’s esophagus – in fact, it develops in less than 10% of people with GERD. It is more common in people who have had GERD for a long time or who were diagnosed with it at a young age.

Learn more about clinical trials for the diagnosis and treatment of Barrett’s Esophagus.

LUCID DIAGNOSTICS PROTOCOL PR-0139 (EG-CL-101) A Multicenter, Single-Arm Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck versus Esophagogastroduodenoscopy for the Diagnosis of Barrett’s Esophagus in an At-Risk Screening Population

LUCID DIAGNOSTICS PROTOCOL PR-0138 (EG-CL-102) A Multicenter Case-Control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett’s Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma

Photo of Jose Nieto D.O.
Gastroenterologist Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: 904680871
Return to top.

Contact Research